Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Thyrocare Technologies has informed that, Nitin Chugh has been appointed as Chief Commercial Officer of the Company, being part of the Senior Management of the Company with effect from February 22, 2024. Further, the details/disclosures required under Regulation 30 of the SEBI Listing Regulations, read the SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are enclosed as Annexure -A.
The above information is a part of company’s filings submitted to BSE.
